Blog

Meeting Report: Society of Interventional Radiology (SIR) 2022

Published:
SIR held its 2022 Annual Meeting in Boston from June 11–16. There were seven scientific presentations on focused ultrasound, and two manufacturers in the field participated. A Foundation-sponsored reception and several educational sessions throughout the meeting focused on cultivating the next generation of interventional radiologists.
Read More ...

Company Profile: Advanced Microbubbles, Inc.

Published:
Advanced Microbubbles is designing and manufacturing custom, size-isolated, ultrasound-triggered microbubbles for drug delivery and gene therapy. The company’s vision is to enable safe and precise cancer chemotherapy using uniform-sized microbubbles. Promising preclinical research suggests that the use of the company’s microbubbles may help control high-risk neuroblastoma.
Read More ...

Focused Ultrasound Liver Tumor Treatment Receives CMS Reimbursement

Published:
The Centers for Medicare and Medicaid Services (CMS) has set a facility procedural payment level of $12,500.50, in addition to the costs associated with single-use devices utilized, for histotripsy of liver tumors. Histotripsy’s novel mechanism of action uses focused ultrasound to mechanically destroy and liquefy targeted liver tissue at sub-cellular levels. HistoSonics is sponsoring ongoing clinical studies in the US and Europe, named #HOPE4LIVER, which are designed to evaluate the safety and technical efficacy of histotripsy in patients with primary and secondary liver tumors.
Read More ...
Meeting Report: Congress of Neurological Surgeons (CNS) Annual Meeting